Latest stories on MSLE
Satellos Bioscience Inc. GAAP EPS of -$0.53
Seeking Alpha38 · neutralearnings
Satellos reports Q3 EPS (53c), consensus (63c)
The Fly38 · neutralearnings
Satellos Reports Third Quarter 2026 Financial Results and Highlights Company Progress
GlobeNewswire56 · neutralearnings
Satellos Reports Third Quarter 2026 Financial Results and Highlights Company Progress
Business Insider58 · neutralearnings
Satellos Changes Primary Endpoint In Basecamp Trial After Fda Feedback
The Fly42 · neutralproduct/pr
Satellos Changes Primary Efficacy Endpoint in BASECAMP Phase 2 Pediatric Trial to MRI-Measured Fat Fraction Following FDA Feedback
Business Insider58 · neutralproduct/pr
Satellos Changes Primary Efficacy Endpoint in BASECAMP Phase 2 Pediatric Trial to MRI-Measured Fat Fraction Following FDA Feedback
GlobeNewswire58 · neutralproduct/pr
Satellos to Host Investor Call to Provide an Update on Clinical and Regulatory Strategy for the BASECAMP Phase 2 Pediatric Study
StockTitan53 · neutralproduct/pr
Satellos to Host Investor Call to Provide an Update on Clinical and Regulatory Strategy for the BASECAMP Phase 2 Pediatric Study
GlobeNewswire52 · neutralproduct/pr
Satellos Establishes Scientific Advisory Board to Explore the Biology of Regeneration in Aging and Neuroscience
StockTitan56 · neutralproduct/pr
Satellos to Participate in Upcoming Investor Conferences
GlobeNewswire52 · neutralproduct/pr
Satellos management to meet with Cantor
The Fly53 · neutralgeneral
Craig-Hallum initiates Satellos with a Buy ahead of BASECAMP data
The Fly63 · neutralanalyst
Satellos initiated with a Buy at Craig-Hallum
The Fly63 · neutralanalyst
Satellos Granted Composition of Matter Patent for Forazapadin
Business Insider63 · neutralproduct/pr
Satellos announces enrollment completed for BASECAMP
The Fly63 · neutralproduct/pr
Satellos Announces Completion of Enrollment in BASECAMP Phase 2 Clinical Trial of Forazapadin for Duchenne Muscular Dystrophy
GlobeNewswire59 · neutralproduct/pr
Satellos stock jumps after FDA clears FSHD trial for forazapadin
Investing.com Markets67 · bullishproduct/pr
Satellos announces U.S. FDA cleared IND application for forazapadin
The Fly63 · neutralproduct/pr
Satellos Bioscience to Showcase Forazapadin Program at World Muscle Society Congress
TipRanks63 · neutralproduct/pr
Satellos to Present at the 31st Annual Congress of the World Muscle Society
Business Insider55 · neutralproduct/pr
Satellos assigns forazapadin name to SAT-3247
The Fly55 · neutralproduct/pr
Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247
GlobeNewswire63 · neutralproduct/pr